Compounds > 3,7-dimethyl-1-propargylxanthine
Page last updated: 2024-08-26

3,7-dimethyl-1-propargylxanthine and Myocardial Ischemia

3,7-dimethyl-1-propargylxanthine has been researched along with Myocardial Ischemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armour, JA; Arora, RC1
Becker, BF; Raschke, P1
Baumann, G; Berndt, T; Felix, SB; Frank, TM; Harms, C; Kästner, R; Stangl, V1
Baumann, G; Buttke, K; Felix, SB; Frank, T; Harms, C; Muss, J; Stangl, K; Stangl, V1
Baumann, G; Felix, SB; Frank, TM; Schrör, K; Stangl, K; Stangl, V1

Other Studies

5 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and Myocardial Ischemia

ArticleYear
Adenosine A1 receptor activation reduces myocardial reperfusion effects on intrinsic cardiac nervous system.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2003, Volume: 284, Issue:5

    Topics: Adenosine; Animals; Female; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Receptors, Purinergic P1; Swine; Theobromine; Xanthines

2003
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia.
    Cardiovascular research, 1995, Volume: 29, Issue:4

    Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines

1995
Release of a stable cardiodepressant mediator after myocardial ischaemia during reperfusion.
    Cardiovascular research, 1997, Volume: 35, Issue:1

    Topics: Adenosine Deaminase; Adrenergic beta-Antagonists; Animals; Autacoids; Catalase; Depression, Chemical; Female; Free Radical Scavengers; Guinea Pigs; Male; Metoprolol; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Naphthalenes; Nitric Oxide Synthase; Nitroarginine; Perfusion; Phospholipases A; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Pyrones; Superoxide Dismutase; Theobromine; Xanthines

1997
Cardiodepressant mediators are released after myocardial ischaemia: modulation by catecholamines and adenosine.
    Acta physiologica Scandinavica, 1999, Volume: 165, Issue:4

    Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Catecholamines; Chromatography, High Pressure Liquid; Guinea Pigs; In Vitro Techniques; Metoprolol; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Theobromine; Ventricular Function, Left; Xanthines

1999
Interaction of adenosine and prostacyclin in coronary flow regulation after myocardial ischemia.
    European journal of pharmacology, 1999, Jul-14, Volume: 377, Issue:1

    Topics: Adenosine; Animals; Cyclooxygenase Inhibitors; Drug Interactions; Epoprostenol; Guinea Pigs; Heart; Hemodynamics; In Vitro Techniques; Indomethacin; Myocardial Ischemia; Perfusion; Purinergic P1 Receptor Antagonists; Theobromine; Time Factors; Vasodilation; Xanthines

1999